Research Library

By Anshul Bhatnagar, Jingbo Niu, Vivian Ho, Wolfgang C. Winkelmayer and Kevin Erickson

Recent initiatives aim to improve…

By Kevin F. Erickson, Melandrea Worsley and Wolfgang C. Winkelmayer

Fifty years ago, on October 30, then-President…

Observations that peritoneal dialysis (PD) may be an effective, lower-cost alternative to hemodialysis for the treatment of ESKD have led to policies encouraging PD and subsequent increases in its use in the United States.

The authors' combined statistical and economic models on specific aspects and properties of biochar will be useful for future field experiment proposals, farmers purchasing biochar, and decision-makers working to incentivize agricultural advances. In GCB-Bioenergy, October 8, 2020, https://onlinelibrary.wiley.com/doi/full/10.1111/gcbb.12765

The authors found that six months of pre–end-stage kidney disease nephrology care did not significantly improve the likelihood that patients would remain employed when they started dialysis. This finding underscores the need to identify effective methods to help patients stay employed when they transition to dialysis.

Expanded “payment bundles” for the treatment of end stage kidney disease did not in general increase the risk of closure by dialysis facilities, the authors conclude.

Consolidated dialysis markets have coincided with both positive and negative trends in health care costs and outcomes. If the underlying mechanisms that contributed to past consolidation persist, dialysis markets may remain highly concentrated over the long term.

In this study, the authors investigate where U.S. patients with limited health insurance coverage receive maintenance dialysis. Journal of the American Society of Nephrology: http://bit.ly/2Q15Jpt

By Kevin F. Erickson, Bo Zhao, Jingbo Niu, Wolfgang C. Winkelmayer, Jay Bhattacharya, Glenn M. Chertow and Vivian Ho The acquisition of independently owned dialysis facilities by facility chains lead to slower decreases in mortality and hospitalization rates, write the authors. JAMA Network Open: https://bit.ly/2WPYGSD

The authors examine the role that government policy can play in accelerating production and use of biochar at commercial scale, such as providing commercial financial incentives, nonfinancial policy support and research and development funding. The article also includes broad recommendations for the development of policy that maximizes the net benefits of biochar adoption.